IQVIA Holdings | IQV - Interest Expense On Debt


IQVIA Holdings reported $203M in Interest Expense on Debt for its fiscal quarter ending in September of 2026.





Interest Expense On Debt Change Date
Accenture USD 103.82M 33.18M Jun/2026
Agilent USD 29M 4M Jun/2026
Bruker USD 17.8M 9.7M Jun/2026
Cardinal Health USD 73M 6M Sep/2026
Celltrion KRW 19B 1.96B Jun/2025
Charles River Laboratories USD 28.52M 1.82M Sep/2026
Cigna USD 157.64B 562M Sep/2026
Cognizant Technology Solutions USD 19M 6M Sep/2026
Cspc Pharmaceutical CNY 6.76M 3.43M Dec/2025
CVS Health USD 747M 10M Sep/2026
Danaher USD 135M 28M Sep/2026
Dentsply International USD 27M 5M Sep/2026
Deva Holding AS TRY 272.53M 69.04M Sep/2023
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 130M 70M Sep/2026
Elevance Health USD 358M 6M Sep/2026
Humana USD 197M 4M Jun/2026
IBM USD 491M 5M Sep/2026
Illumina USD 24M 0 Sep/2026
Infosys INR 1.15B 100M Sep/2026
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Laboratory Of America USD 59.1M 2M Sep/2026
McKesson USD 105M 28M Sep/2026
Mettler Toledo International USD 15.68M 1.57M Sep/2026
Organigram Holdings CAD 179K 127K Mar/2025
Ovoca Bio EUR 7K 6K Jun/2022
Pharma Mar EUR 117K 1.24M Sep/2025
Publicis EUR 51M 10M Jun/2025
Qiagen NV USD 10.02M 1.03M Jun/2026
Quest Diagnostics USD 61M 8M Sep/2026
Revvity USD 20.81M 2.18M Sep/2026
Sartorius EUR 44.9M 4.6M Sep/2026
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Thermo Fisher Scientific USD 417M 63M Sep/2026
Tilray USD 6.7M 2.73M Jun/2025
UnitedHealth USD 963M 1000K Sep/2026
Veeva Systems USD 74.42M 9.32M Mar/2026
Veradigm USD 1.25M 641K Sep/2022
Waters USD 53M 2M Sep/2026
Zealand Pharma A/S 7.07M 74K Dec/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025